Search - tctmd.com

Displaying 441 - 460 of 1248

Sort: Relevancy | Date

Presentation TCT 2023

TCT 378: A novel miRNA nanocarrier for local device-based pharmacotherapy

Presenter: Stephanie Bettink

October 26, 2023

Presentation TCT 2023

TCT 320: Performance of a Novel Sirolimus-Coated Balloon According to Clinical Presentation: the Eastbourne-Peace Substudy

Presenter: Alessandra Laricchia

October 26, 2023

Presentation TCT 2023

TCT 277: Comparison of Change in Side-Branch Ostium after Drug-Coated Balloon versus Drug-Eluting Stent versus Medication for the Treatment of De Novo Coronary Bifurcation Lesions

Presenter: Ae-Young Her

October 26, 2023

Presentation TCT 2023

Novel Solutions for High Bleeding Risk Patients

Presenter: Bjorn Redfors

October 26, 2023

Presentation TCT 2023

TCT 846: First-in-Human Treatment of Severe Tricuspid Regurgitation using a novel Cross-Caval Heterotopic Device

Presenter: Rodrigo Estevez-Loureiro

October 26, 2023

Presentation TCT 2023

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

Presenter: Jens Erik Nielsen-Kudsk

October 25, 2023

Presentation TCT 2023

TCT 817: ABSORB bioresorbable scaffold (BRS) late restenosis treated with novel Magmaris BRS

Presenter: Jorgo Kostov

October 25, 2023

Presentation TCT 2023

A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results

Presenter: Isaac George

October 25, 2023

Presentation TCT 2023

TCT 433: Clinical and Procedural Outcomes of Percutaneous Coronary Intervention for De Novo Lesions involving the Ostial Left Circumflex Coronary Artery

Presenter: Ottavia Cozzi

October 25, 2023

Presentation TCT 2023

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

Presenter: Philipp Lurz

October 25, 2023

Presentation TCT 2023

TCT 799: Enhanced Stent Visualization Guided Intravascular Lithotripsy for Severely Calcified Coronary Lesions: A Novel Technique for Advancing IVL Balloons in Uncrossable Lesions

Presenter: Nobuki Matsuna

October 25, 2023

Presentation TCT 2023

Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)

Presenter: Joo-Yong Hahn

October 25, 2023

Presentation TCT 2023

TCT 434: Clinical Update on a Novel Completely Extravascular Temporary Pacing Lead System

Presenter: Gary Gershony

October 25, 2023

Presentation TCT 2023

TCT 662: Long-term Clinical Outcomes from 2 European Centres Following the Use of Sirolimus-Coated Balloon in Small Vessel and Long-Lesions in De-novo Segments

Presenter: Sandeep Basavarajaiah

October 25, 2023

Presentation TCT 2023

TCT 678: Long-term Follow-up From the Use of Sirolimus Coated Balloons in De-novo Coronary lesions in a Real-World Population from 3 High Volume European Centers

Presenter: Sandeep Basavarajaiah

October 25, 2023

Presentation TCT 2023

TCT 658: Novel electrocardiogram generating technique using artificial intelligence: from 2-lead to 12-lead

Presenter: Hak Seung Lee

October 25, 2023

Presentation TCT 2023

TCT 555: NIRS-Detected Lipid-Rich Plaques are Highly Responsive to Novel Escalated LDL-C Reduction Therapy

Presenter: Karlis Trusinskis

October 25, 2023

Presentation TCT 2023

TCT 649: Impact of a Novel Hybrid Nano-coated Nitinol Drug-eluting Stent (Hybrid-DES) on Below-the-knee Atherosclerotic Disease: 2023 Update

Presenter: Terumitsu Hasebe

October 25, 2023

Presentation TCT 2023

TCT 540: 12-Month Clinical Outcomes of Patients Treated with the novel DynamX Bioadaptor: DynamX Hong Kong Registry

Presenter: Wai Kin Chi

October 25, 2023

Presentation TCT 2023

TCT 284: Do the Novel Pulmonary Risk Factors Identified by the Machine Learning Have an Impact on Outcomes of Revascularisation in Complex Coronary Artery Disease?

Presenter: SHIGETAKA KAGEYAMA

October 25, 2023

Advertisement

TCT 378: A novel miRNA nanocarrier for local device-based pharmacotherapy

TCT 320: Performance of a Novel Sirolimus-Coated Balloon According to Clinical Presentation: the Eastbourne-Peace Substudy

TCT 277: Comparison of Change in Side-Branch Ostium after Drug-Coated Balloon versus Drug-Eluting Stent versus Medication for the Treatment of De Novo Coronary Bifurcation Lesions

Novel Solutions for High Bleeding Risk Patients

TCT 846: First-in-Human Treatment of Severe Tricuspid Regurgitation using a novel Cross-Caval Heterotopic Device

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

TCT 817: ABSORB bioresorbable scaffold (BRS) late restenosis treated with novel Magmaris BRS

A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results

TCT 433: Clinical and Procedural Outcomes of Percutaneous Coronary Intervention for De Novo Lesions involving the Ostial Left Circumflex Coronary Artery

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

TCT 799: Enhanced Stent Visualization Guided Intravascular Lithotripsy for Severely Calcified Coronary Lesions: A Novel Technique for Advancing IVL Balloons in Uncrossable Lesions

Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)

TCT 434: Clinical Update on a Novel Completely Extravascular Temporary Pacing Lead System

TCT 662: Long-term Clinical Outcomes from 2 European Centres Following the Use of Sirolimus-Coated Balloon in Small Vessel and Long-Lesions in De-novo Segments

TCT 678: Long-term Follow-up From the Use of Sirolimus Coated Balloons in De-novo Coronary lesions in a Real-World Population from 3 High Volume European Centers

TCT 658: Novel electrocardiogram generating technique using artificial intelligence: from 2-lead to 12-lead

TCT 555: NIRS-Detected Lipid-Rich Plaques are Highly Responsive to Novel Escalated LDL-C Reduction Therapy

TCT 649: Impact of a Novel Hybrid Nano-coated Nitinol Drug-eluting Stent (Hybrid-DES) on Below-the-knee Atherosclerotic Disease: 2023 Update

TCT 540: 12-Month Clinical Outcomes of Patients Treated with the novel DynamX Bioadaptor: DynamX Hong Kong Registry

TCT 284: Do the Novel Pulmonary Risk Factors Identified by the Machine Learning Have an Impact on Outcomes of Revascularisation in Complex Coronary Artery Disease?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content